Doxycycline for Sexually Transmitted Diseases

(DOSE Trial)

UV
Overseen ByUCLA Vine Street Clinic
Age: 18+
Sex: Male
Trial Phase: Phase 4
Sponsor: University of California, Los Angeles
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this clinical trial is to learn if three different dosing strategies of doxycycline (daily, weekly, and on-demand) works to prevent sexually transmitted infections (gonorrhea, chlamydia, and syphilis) among men who use methamphetamine and who have sex with other men. The main question it aims to answer is:

Does daily, weekly, and on-demand doxycycline dosing strategies lower the incidence of quarterly STIs (gonorrhea, chlamydia, and syphilis)?

Participants will:

Take doxycycline either on-demand (within 72 hours after sex), daily, or weekly doxycycline for one year Visit the clinic once every 3 months to complete questionnaires, undergo HIV/STI testing, and collect samples. Additional visits may be needed to receive STI treatment.

Complete text surveys once every month

Who Is on the Research Team?

CB

Cherie Blair, MD, PhD

Principal Investigator

University of California, Los Angeles

Are You a Good Fit for This Trial?

This trial is for men who have sex with men, use methamphetamine (chemsex), and are at risk of getting sexually transmitted infections like gonorrhea, chlamydia, or syphilis. Participants must be willing to take doxycycline in one of three dosing schedules and attend regular clinic visits.

Inclusion Criteria

I was diagnosed with an STI in the past year.
Reports MA use in conjunction with CAI with a male partner in the 30 days prior to screening
Willing and able to give written informed consent
See 4 more

Exclusion Criteria

Reported allergy to tetracyclines
I am currently using or planning to use doxycycline for more than 2 weeks.
I have used antibiotics for more than 2 weeks in the past month, except doxyPEP.
See 3 more

What Are the Treatments Tested in This Trial?

Interventions

  • Doxycycline Hyclate

Trial Overview

The study compares three ways of taking doxycycline—daily, weekly, or only after sex—to see which best prevents STIs over a year. Participants are randomly assigned to one group and monitored every three months.

How Is the Trial Designed?

3

Treatment groups

Experimental Treatment

Group I: Weekly doxycyclineExperimental Treatment1 Intervention
Group II: On-demand doxycyclineExperimental Treatment1 Intervention
Group III: Daily doxycyclineExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, Los Angeles

Lead Sponsor

Trials
1,594
Recruited
10,430,000+

National Institute on Drug Abuse (NIDA)

Collaborator

Trials
2,658
Recruited
3,409,000+